NCT02520115 2019-08-14
Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer
Barbara Ann Karmanos Cancer Institute
Phase 1 Completed
Clinical Trials
5 trialsNCT00529022 2013-02-20
Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00532818 2009-03-30
Hydralazine Valproate for Cervical Cancer
National Institute of Cancerología
Phase 3 Unknown
NCT00533299 2007-09-21
Hydralazine Valproate for Ovarian Cancer
National Institute of Cancerología
Phase 3 Unknown
NCT00404326 2006-11-28
Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer
National Institute of Cancerología
Phase 2 Completed